fenobam
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00637221)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Metabotropic glutamate receptor 5ANTAGONIST
GRM5 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1- Mol. weight
- 266.69 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL239800 ↗
- ChEMBLCHEMBL2103779 ↗
Also known as
- fenobam
- fenobam
- fenobam
- fenobam
- fenobam
- fenobam anhydrous
- fenobam anhydrous
- fenobam anhydrous
- fenobam hydrate
- fenobam monohydrate
- mcn-3377-98
- mcn-3377-98
- npl-2009
- npl-2009
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01981395 | Phase 1 | Jan 1, 2014 | Washington University in St. Louis |
| NCT01806415 | Phase 1 | May 1, 2013 | Washington University in St. Louis |
| NCT00637221 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Neuropharm |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 2 | 2 | 1 | 2013 |
| Neuropharm | For profit | 1 | 1 | 1 | 2008 |
2 organizations
Page 1 / 1